poisar

Stocks · News reference

Wells Fargo Maintains Overweight on CME Group, Raises Price Target to $315

Benzinga Newsdesk

Wells Fargo analyst Daniel Welden maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $301 to $315.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CME
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Sean Williams

    There's a 35% Chance That the Fed Hikes Rates at Least 4 Times by September 2027, Which Can Decimate the AI-Driven Bull Market

    The Federal Reserve has begun a rate-hiking cycle under Chair Kevin Warsh, with a 35% probability of at least four quarter-point rate hikes by September 2027, driven by persistent inflation from Trump's tariffs and geopolitical tensions. Rising borrowing costs could slow AI infrastructure investments and threaten the historically expensive, AI-driven bull market that has driven recent stock market gains.

    CME
  3. Zacks.Com

    CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    CME Group is expected to report Q3 2026 earnings of $2.96 per share (up 10.5% YoY) with revenues of $1.71 billion (up 11.4% YoY) on October 21. The company has a positive Earnings ESP of +1.56% combined with a Zacks Rank #3, suggesting a likely earnings beat. CME has beaten consensus estimates in 3 of the last 4 quarters.

    CME